TrialThe Lancet. Respiratory medicine2022

Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial.

Hugh Montgomery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.